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SUMMARY 
Acute lithium intoxication is well known. A case of long tasting lithium neurotoxicity in an adolescent male is 
reported, who showed signs of cerebellar as well as brain stem involvement. Persistent lithium neurotoxicity is 
discussed and the recommendation made that this condition be considered irreversible only if no substantial 
recovery occurs in the first six months. 
Long-lasting neurological sequelae are known to oc-
casionally follow acute lithium intoxication. While a 
variety of signs are reported in the stage of acute intoxica-
tion, the sequelae largely consists of a cerebellar 
syndrome. Donaldson and Cunningham (1983) reviewed 
17 such cases, with a mean age of 54 years. Schou (1984) 
in acombined literature review and correspondence follow 
up provided information about the development and fur-
ther course of long-lasting neurologic sequelae after 
lithium intoxication in 40 patients. The mean age of the 
sample was 48 years (range 28-67). Such a complication 
has not been reported in children. However, young patients 
are now treated more frequently with lithium than in the 
past. The case of an adolescent boy who developed such 
lithium neurotoxicity is reported. 
CASE REPORT 
S.M., a 15 year-old boy was brought to us on January 
24, 1990 with complaints of fever, marked weakness, 
tremulousness and inability to swallow, speak or stand. He 
had two past episodes of mania in September 1987 and 
November 1989 and was on lithium carbonate (750 
mg/day) and haloperidol (10 mg/day). There was no his-
tory suggestive of pre-existing brain organicity. On 
January 10,1990 he was found to be febrile. For the first 
three days the fever was low grade and most noticeable in 
the evening. Later it was continuous and ranged from 38.5 
to 39 degrees centigrade and was accompanied by 
anorexia and intermittent non-projectile vomiting. He was 
taken to a local hospital and treated symptomatically. For 
the first nine days of the febrile illness he continued to take 
lithium and haloperidol, at first continuously and then 
intermittently, before finally stopping it on January 20. 
On examination, he was febrile without any obvious 
focus of infection. There was no alteration in sensorium 
and vital signs were normal. He had marked parkinsonian 
features (masked fades, sialorrhoea, loss of associated 
movements and cog-wheel rigidity) and a prominent 
cerebellar syndrome (dysarthria, ataxia, dysmetria, dys-
diadcchokinesia and intention tremor). He was dysphasic 
and had paresis of the tongue and facial muscles (UMN 
type). Jaw jerk, gag and palatal reflexes were normal. Deep 
tendon reflexes were brisk bilaterally and plantars flexor. 
There was no sensory deficit. Within two days of 
hospitalization, S.M. showed emotional incontinence in 
the form of involuntary laughs lasting for a few minutes. 
Serum lithium estimation on the day of admission was 
0.4 meq/1. Laboratory tests(total and differential leucocyte 
count, erythrocyte sedimentation rate, plasma electrolytes, 
blood urea, serum creatinine, and liver function tests) were 
within normal limi's. Lumbar puncture was traumatic and 
CSF examination revealed glucose 75 mg% (N= 50-65 
mg%), protein 76 mg % (N= 15-45 mg%), erythrocytes 
200-300 and leucocytes 1-2 per high power field. CPK 
estimation could not be done. X ray chest, skull and CT 
scan were normal. EEG was abnormal, suggestive of 
multiple independent focal spike and slow waves bilateral-
ly, more on the right side, in occipital, posterotemporal, 
parietal and central areas, and left anterior temporal areas. 
Treatment was initiated with benztropine mesylate, 
erythromycin and supportive measures. Within 24 hours 
he developed urinary retention and benztropine was dis-
continued. By day four of hospitalization, he was afebrile 
and his general condition started improving. Over the next 
three months of hospitalization he showed gradual im-
provement in neurological symptoms. Parkinsonian 
symptoms remitted first, followed by paresis of tongue and 
facial muscles, and emotional incontinence. Partial im-
provement in ataxia, dysmetria and intention tremor 
enabled him to take care of his basic needs. Significant 
dysarthria, however, persisted. 
Over the next six months of domiciliary speech therapy 
and physiotherapy there was almost complete recovery of 
all functions. At this point in time, he developed 
hypomanic symptoms and was successfully treated and 
maintained on carbamazepine (600 mg/day). At the time 
oflatestfollow-up(correspondence)hecontinued to main-
tain improvement. 
DISCUSSION 
There is controversy whether lithium-neuroleptic 
neurotoxicity is a distinct diagnostic entity or simply rep-
resents atypical cases of lithium toxicity or neuroleptic 
malignant syndrome (Ross & Caffey, 1978). The pos-
sibility of "irreversible brain damage" caused by a com-
bination of lithium and haloperidol raised by a small series 
of cases is discounted by larger series which show no such 
occurrence (Baastrup et al, 1976). Our case initially 
showed features of lithium toxicity as well as haloperidol 
induced parkinsonian symptoms, but the later picture was 
dominated by those symptoms reported as long lasting 
neurological sequelae of lithium carbonate toxicity. Most 
cases are reported to have a mixture of signs, suggesting 
damage at multiple sites in the nervous system, and some 
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patients are reported to show brain stem features 
(Donaldson & Cunningham, 1983; Schou, 1984), though 
features of pseudobulbar palsy have not been specifically 
reported. 
Fever is known to be a common preci pi tati ng factor for 
long lasting neurologic sequelae to lithium intoxication 
(Schou, 1984). Serum lithium levels are in some cases 
below the toxic range (Adityanjee, 1987; Verdoux & 
Bourgeois, 1990), but more often long-lasting neurologic 
sequelae follow lithium intoxication (Schou, 1984). While 
some cases are due to intentional overdoses, the majority 
develop under circumstances when lithium administration 
should have been stopped. Low serum lithium levels are 
often due to the considerable delay in drawing blood 
samples, as in this case. 
Long-lasting neurological sequelae have been ar-
bitrarily defined as those persisting for two months after 
the discontinuation of lithi urn (Schou, 1984). Tesio (1987) 
proposed that the minimal criteria for "irreversible lithium 
effectuated neurotoxicity" should include persistence of 
cerebellar signs six months after poisoning and discon-
tinuation of lithium. However, in our case, although sub-
stantial improvement occurred in the first 6 months, 
further improvement continued and by the end of 9 months 
recovery was almost complete. In order to avoid 
therapeutic nihilism, we propose that the condition should 
be considered irreversible only if no substantial (say less 
than 50%) recovery takes place in the first 6 months. 
Keeping in mind the severity of the symptoms and the 
prolonged course of the neurological deficits, no effort 
should be spared to avoid this complication of lithium. 
Besides providing better information to physician and 
patients, it may be useful to insist on patients lithium 
therapy to carry a small card stating, "In case of early signs 
of dehydration or neurological symptoms lithium ad-
ministration must be stopped and a physician contacted". 
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